Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Radiology|February 1, 1984
Selection criteria for upper gastrointestinal examinations: attempts at improvementB J McNeil, A Wijesinha, T E Bynum, et al.
Cancer|February 26, 1998
Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trial: The Radiologic Diagnostic Oncology Group 5 Study. The RDOG5 investigatorsE D Pisano, L L Fajardo, J Tsimikas, et al.
Radiology|March 1, 1985
Excretory urography in current practice: evidence against overutilizationP Doubilet, B J McNeil, F X Van Houten, et al.
The New England Journal of Medicine|September 6, 1990
Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trialM D Rifkin, E A Zerhouni, C A Gatsonis, et al.
Radiology|January 1, 1997
CT and MR imaging in the local staging of primary malignant musculoskeletal neoplasms: Report of the Radiology Diagnostic Oncology GroupD M Panicek, C Gatsonis, D I Rosenthal, et al.
Investigative Radiology|May 1, 1993
The General Electric-Association of University Radiologists Radiology Research Academic Fellowship (GERRAF). An industry-academic collaboration to improve clinical research in radiologyB J Hillman, D G Fryback, R W Holden, et al.
Radiology|May 29, 2001
Fine-needle aspiration biopsy of nonpalpable breast lesions in a multicenter clinical trial: results from the radiologic diagnostic oncology group VE D Pisano, L L Fajardo, D J Caudry, et al.
Radiology|August 1, 1996
CT and MR imaging in the staging of colorectal carcinoma: report of the Radiology Diagnostic Oncology Group IIE A Zerhouni, C Rutter, S R Hamilton, et al.
Radiology|July 16, 1999
Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis--report of the Radiology Diagnostic Oncology GroupA B Kurtz, J V Tsimikas, C M Tempany, et al.
Pageof 16